HROW today
$30.25+$1.95 (+6.89%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bullish
1 hourLeaning Bullish
15 minStrong Bullish
5 minExpanding
Daily trend turns up above $30.28
Key levels
Resistance$33.68
Resistance$31.90
Support$29.54
Support$27.75
Latest news & SEC filings
AnalystBTIG Reiterates Buy Rating on Harrow With $63 Price Target
All HROW news →About Harrow
Harrow is an ophthalmic pharmaceutical company serving eyecare professionals in the U.S. and Canada. It markets FDA-approved eye treatments for conditions such as dry eye disease, cataracts, glaucoma, and retinal diseases, including IHEEZO, VEVYE, and TRIESENCE. Through its ImprimisRx business, it also supplies compounded ophthalmic formulations to prescribers and institutions from facilities in New Jersey. The company is developing additional ophthalmic and procedural sedation therapies.
Based on the company's 10-K filed Mar 2, 2026.
Nasdaq · Healthcare
HARROW, INC. (HROW)
What Is the Price Target for HROW?
SEPT Low Target
$45.00
SEPT Mid Target
$63.00
SEPT High Target
$88.00
Analyst Consensus
$63.00
Is HROW a Buy or Sell Right Now?
Thesis
- •Revenue growing 36.4% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for HROW.
Start Free Trial →Is HROW Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$47.50
33
Moat Score
NONE
5/9
Piotroski Score
2.4
Altman Z-Score
What Is Smart Money Doing with HROW?
Insider Signal
NEUTRAL
4 buys / 5 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Graves Adrienne L | director | Buy | 1,000 | $31K | May 18, 2026 |
| SILVERNAIL LAUREN P | director | Buy | 1,000 | $31K | May 18, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →HROW Growth Story
Revenue YoY
36.4%
3yr Revenue CAGR
45.4%
EPS Growth YoY
71.43%
FCF Growth YoY
280.6%
Revenue Trend
STRONG
Dark Pool Trades for HROW
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for HROW, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:47:23 | $30.31 | 2,400 | $$73K | BUY |
| 16:14:48 | $30.33 | 1,000 | $$30K | BUY |
| 16:05:54 | $30.18 | 2,722 | $$82K | SELL |
| 15:58:59 | $30.41 | 1,000 | $$30K | SELL |
| 15:58:41 | $30.41 | 5,000 | $$152K | BUY |
5 dark pool trades shown · $$368K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for HROW
PREVIEWSEPT Investing provides real-time options flow tracking for HROW, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $40 | Jan 15 | 63 | $$20 | 1 | SWEEP |
| CALL | $35 | Dec 17 | 399 | $$590 | 1 | SWEEP |
| CALL | $15 | Dec 17 | 399 | $$8350 | 5 | SWEEP |
| CALL | $32 | Mar 19 | 126 | $$80.0K | 200 | BLOCK |
| CALL | $32 | Mar 19 | 126 | $$8400 | 21 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for HARROW, INC. (HROW) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →HROW — frequently asked questions
What is HROW stock price today?
HARROW, INC. (HROW) is at $30.25, up 6.89% (+$1.95) at the Nov 13, 2026 close.
Why is HROW stock moving today?
Latest HROW news — Nov 11, 2026: BTIG Reiterates Buy Rating on Harrow With $63 Price Target
What is the HROW price target?
The average analyst price target for HROW is $63.00, ranging from $45 to $88, based on 3 analysts.
What do analysts rate HROW?
Analyst ratings for HROW: 9 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did HROW beat earnings?
HROW last reported on Aug 10, 2026: EPS -$0.46 vs -$0.18 expected — a miss of 157.3%.
Does HROW pay a dividend?
HROW does not currently pay a dividend.
What are HROW support and resistance levels?
Support: $29.54, $27.75, $25.76. Resistance: $31.90, $33.68, $36.25.
What are insiders doing with HROW?
Insider activity: NEUTRAL, 4 buys and 5 sells in the last 90 days.
What is the latest news on HROW?
Nov 11, 2026: BTIG Reiterates Buy Rating on Harrow With $63 Price Target